Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05680740 · ClinicalTrials.gov registry record · Phase 4
A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis
A Phase 4 study, sponsored by Organon and.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT05680740 is a Phase 4 study that has completed, run by Organon and. The registered enrollment target is 34 participants.
The verdict
NCT05680740, a Phase 4 study, has completed, sponsored by Organon and.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with intertriginous psoriasis
Interventions
- DRUG VTAMA® (tapinarof) Cream 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-12-27 |
| Est. Completion | 2023-05-25 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05680740
The ClinicalTrials.gov registry entry for NCT05680740 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Organon and, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VTAMA® (tapinarof) Cream 1% is the first listed.
NCT05680740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05680740 about?
NCT05680740 is a clinical study titled "A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque Psoriasis". This is an open-label, multi-center study to evaluate the efficacy and safety of VTAMA (tapinarof) cream, 1% in adults with intertriginous psoriasis
What is the current status of trial NCT05680740?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2022-12-27. Estimated completion is 2023-05-25.
What interventions are being tested in trial NCT05680740?
The interventions under investigation include: VTAMA® (tapinarof) Cream 1% (DRUG).
Who is sponsoring clinical trial NCT05680740?
This trial is sponsored by Organon and, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.